—A balance-restoring, comprehensive formulation of CBD, DHA & Turmeric—
Westminster, Colo. (Feb. 3, 2020) ─ Elixinol, a global CBD brand, released its latest product Omega Turmeric CBD Capsules. The first in a line of several upcoming new product launches that are specific and prescriptive, Elixinol’s Omega Turmeric CBD Capsules combine turmeric—widely considered one of the most powerful antioxidants supplements—with CBD-rich full spectrum hemp oil and algae-derived DHA to create a comprehensive formulation that restores balance and eases everyday discomfort.
Studies have shown that curcumin also helps the body absorb DHA, an omega-3 fatty acid that helps support brain function and ease joint discomfort. Omega-3 acids have a direct impact on the human endocannabinoid system. Elixinol’s full-spectrum hemp oil is rich in CBD and boasts a complete range of complementary cannabinoids, flavonoids and terpenes. Each Omega Turmeric CBD Capsule contains 15mg of CBD, 237mg of curcumin and 120mg of DHA.
“Adding the Omega Turmeric CBD Capsules to the Elixinol portfolio of products gives consumers another choice when addressing their health and wellness needs,” said Leif Harrison, CEO, Americas, Elixinol. “The ingredients in this product are naturally complementary, working together to help our customers restore balance in their day-to-day lives.”
All of Elixinol’s products undergo rigorous, pharmaceutical-grade testing to ensure the absence of microbiological contamination, heavy metals and pesticides, as well as the presence of Elixinol’s unique terpene profile. The products are formulated to enable the entourage effect, which harnesses the interactive synergies of all those ingredients to provide maximum therapeutic benefits.
Elixinol will roll out its new brand look along with innovative novel products at Natural Products Expo West Booth 2637 in Anaheim, Calif., March 3-7. For more information or to schedule a briefing, please contact Shawna Seldon McGregor at 917-971-7852 or [email protected].
With a proven track record of growing and extracting premium-quality hemp, Elixinol is one of the few CBD hemp extract brands with complete seed-to-sale control over its products. Elixinol also conducts rigorous third-party laboratory testing and quality control. Elixinol distributes hemp-derived CBD products in 40 countries globally including North and South America, throughout Europe, Asia, and the Pacific Region under its own label as well as bulk CBD and wholesale CBD. Elixinol’s parent company EXL (elixinolglobal.com) is publicly traded on the Australian Securities Exchange and on the U.S. OTC (ASX:EXL, OTCQX:ELLXF). More information available at Elixinol.com.